Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort-Reference-Cited by-同舟云学术

Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort

Published:2020-08 Issue:8 Volume:19 Page:102595
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Roberts Janet,Ennis Daniel,Hudson Marie,Ye Carrie,Saltman Alexandra,Himmel Megan,Rottapel Robert,Pope Janet,Hoa Sabrina,Tisseverasinghe Annaliese,Fifi-Mah Aurore,Maltez Nancy,Jamal Shahin

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Novel immune check point inhibiting antibodies in cancer therapy-opportunities and challenges;Diesendruck;Drug Resist Updat,2017

3. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline;Brahmer;J Clin Oncol,2018

4. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) toxicity management working group;Puzanov;J Immunother Cancer,2017

5. Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Haanen;Ann Oncol,2017

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms;Autoimmunity Reviews;2024-07

2. Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update;Journal for ImmunoTherapy of Cancer;2024-07

3. A case report of immune checkpoint inhibitor‐related myositis and cholangitis induced by pembrolizumab;Clinical Case Reports;2024-07

4. Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy;Melanoma Research;2024-07-01

5. Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management;Expert Review of Clinical Immunology;2024-06-25